CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Ergomed PLC Company Snapshot
Ergomed PLC operates within the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Ergomed PLC with three other companies in this sector in the United Kingdom: Circassia Pharmaceuticals PLC (2018 sales of £48.30 million [US$62.73 million] of which 57% was operating-NIOX), GW Pharmaceuticals PLC (£20.00 million [US$25.98 million] of which 100% was Novel Therapeutics), and Oxford BioMedica plc (£66.78 million [US$86.72 million] of which 82% was Platform).

Sales Analysis. During the year ended December of 2018, sales at Ergomed PLC were £54.11 million (US$70.28 million). This is an increase of 13.6% versus 2017, when the company's sales were £47.62 million. This was the fifth consecutive year of sales increases at Ergomed PLC (and since 2013, sales have increased a total of 257%). Sales of Drug Safety and Medical Information Serv saw an increase of 22.4% in 2018, from £22.49 million to £27.53 million.
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Ergomed PLC
  Stock Performance Chart for Ergomed PLC
 
  Stock Data: Recent Stock Performance:
  Current Price (11/29/2019): 378.00p
(Figures in Pounds Sterling)
1 Week -2.3%   13 Weeks 16.3%  
4 Weeks 12.8%   52 Weeks 147.9%  
 
Ergomed PLC Key Data:
  Ticker: ERGO Country: United Kingdom
  Exchanges: LON Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2018 Sales 54,112,000
(Year Ending Jan 2019).
Employees: 702
  Currency: Pounds Sterling Market Cap: 176,591,817
  Fiscal Yr Ends: December Shares Outstanding: 46,717,412
  Share Type: Ordinary Closely Held Shares: 15,829,336
 
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.